Combined data from five implantable cardioverter-defibrillator (ICD) trials suggest that it is the underlying arrhythmic disorder, rather than the ICD therapy itself, that affects mortality in these ...

WASHINGTON -- Researchers made a strong case that earlier was better when it comes to catheter ablation of ventricular tachycardias (VTs) in people with implantable cardiac defibrillators (ICDs).

Ventricular tachycardia (VT) ablation should be considered after the first implantable cardioverter defibrillator (ICD) shock in patients with ischemic or nonischemic cardiomyopathy, the PARTITA trial ...

Please provide your email address to receive an email when new articles are posted on . A single burst of antitachycardia pacing (ATP) reduced risk for shocks in patients with an implantable ...

The first randomized trial to investigate preventive ablation of a potential arrhythmogenic substrate associated with coronary chronic total occlusion (CTO) in patients at high risk of ventricular ...

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Ablation soon after first implantable cardioverter defibrillator shock for ventricular tachycardia ...

(HealthDay News) — For patients with cardiomyopathy, use of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) is associated with significantly lower incidence of ...

Primary prevention implantable cardioverter-defibrillators (ICDs) equipped for antitachycardia pacing (ATP) offered fewer first device shocks but perhaps at a cost, the APPRAISE ATP randomized trial ...

An implantable cardioverter defibrillator (ICD) is a heart monitoring device. When necessary, it provides an electric shock that corrects an abnormal heart rhythm and prevents sudden cardiac death.

SAN FRANCISCO, CA—The subcutaneous implantable cardioverter-defibrillator (S-ICD; Boston Scientific) prevents most of the major lead-related complications seen with a transvenous system, the ATLAS ...

In a typical population of patients requiring implantable cardioverter-defibrillator (ICD) therapy without pacing, mostly for the primary prevention of sudden cardiac death, a subcutaneous ICD (S-ICD; ...